Details on the applications and licences for Dealings involving an intentional release (DIR) of a GMO into the environment.
Dealings involving an Intentional Release (DIR) of GMOs into the environment are dealings with GMOs which can take place outside of containment facilities.
Trial of a genetically modified vaccine against devil facial tumour disease in Tasmanian devils
University of Tasmania Veterinary Limited and controlled Application under evaluation
Limited and controlled release of perennial ryegrass genetically modified for increased metabolisable energy content
Grasslanz Technology Australia Pty Limited Agricultural Limited and controlled Application under evaluation
Commercial supply of a genetically modified vaccine against infectious laryngotracheitis virus in chickens
Bioproperties Pty Ltd Veterinary Commercial Application under evaluation
Clinical trial of a genetically modified (GM) chimeric Orthopoxvirus (CF33-hNIS) as a cancer treatment
Medpace Australia Pty Ltd Medical Limited and controlled 15 September 2022 Current
Commercial import and distribution of chrysanthemum genetically modified for altered flower colour
International Flower Developments Pty Ltd Agricultural Commercial Application under evaluation
Commercial release of Indian mustard genetically modified for herbicide tolerance (RF3)
BASF Australia Ltd Agricultural Commercial 13 October 2022 Current
Limited and controlled release of sorghum genetically modified for asexual seed formation
The University of Queensland Agricultural Limited and controlled 23 June 2022 Current
Limited and controlled release of canola and Indian mustard genetically modified for altered oil content and herbicide tolerance
Nuseed Pty Ltd Agricultural Limited and controlled 8 June 2022 Current
Clinical trial of a genetically modified alphavirus for treatment of cancer
VRT Pharmaceuticals Pty Ltd Medical Limited and controlled Ceased to consider
Limited and controlled release of wheat and barley genetically modified for yield enhancement and improved abiotic stress tolerance
The University of Adelaide Agricultural Limited and controlled 15 February 2022 Current
Clinical trial with a genetically modified Bordetella pertussis for the prevention of whooping cough
PPD Australia Pty Ltd Medical Limited and controlled 8 December 2021 Current
Clinical trial with a genetically modified human adenovirus COVID-19 vaccine
Avance Clinical Pty Ltd Medical Limited and controlled 25 June 2021 Current
Clinical trial with genetically modified E.coli to reduce antibiotic resistance
The Westmead Institute for Medical Research Medical Limited and controlled 20 July 2021 Current
Commercial supply of a genetically modified COVID-19 vaccine
Janssen-Cilag Pty Ltd Medical Commercial 19 April 2021 Current
Clinical trial of a genetically modified Herpes virus for the treatment of cystic fibrosis
Novotech (Australia) Pty Limited Medical Limited and controlled 7 July 2021 Current
Commercial supply of a genetically modified COVID-19 vaccine
AstraZeneca Pty Ltd Medical Commercial 8 February 2021 Current
Clinical trial with a genetically modified Vaccinia virus based treatment for solid cancerous tumours
Novotech (Australia) Pty Limited Medical Limited and controlled 14 April 2021 Current
Commercial release of canola genetically modified for herbicide tolerance and a hybrid breeding system (MS11× RF3 and MS11 × RF3 × MON 88302)
BASF Australia Ltd Agricultural Commercial 16 September 2021 Current
Clinical trial of genetically modified human adenovirus for bladder cancer treatment
Novotech (Australia) Pty Limited Medical Limited and controlled 1 February 2021 Current
Limited and controlled release of white clover genetically modified for increased condensed tannins
Grasslanz Technology Australia Pty Limited Agricultural Limited and controlled 31 March 2021 Current
Commercial release of canola (Brassica napus) genetically modified for herbicide tolerance and a hybrid breeding system (MS11)
BASF Australia Ltd Agricultural Commercial 12 May 2021 Current
Commercial supply of a genetically modified cholera vaccine, Vaxchora®
Biocelect Pty Ltd Medical Commercial 17 February 2021 Current
Commercial release of cotton genetically modified for herbicide tolerance (MON 88701)
Monsanto Australia Pty Ltd Agricultural Commercial 15 October 2020 Current
Withdrawn prior to assessment Limited and controlled Withdrawn
Clinical trial of genetically modified influenza vaccine (H3N2 M2SR)
Novotech (Australia) Pty Ltd Medical Limited and controlled 10 June 2020 Current
Trial of genetically modified vaccines against Ross River virus infection in horses
The University of Queensland Agricultural Limited and controlled 23 January 2020 Surrendered
Limited and controlled release of microalgae genetically modified for increased production of fatty acids
The University of Queensland Other Limited and controlled 16 January 2020 Current
Withdrawn prior to assessment Limited and controlled Withdrawn
Trial of genetically modified vaccines against Ross River virus infection in horses
The University of Queensland Agricultural Limited and controlled Withdrawn
Limited and controlled release of chickpea genetically modified for drought and other environmental stress tolerance
Queensland University of Technology Agricultural Limited and controlled 28 May 2019 Current
Limited and controlled release of wheat genetically modified for altered iron uptake, transport and bioavailability
The University of Melbourne Agricultural Limited and controlled 17 April 2019 Current
Limited and controlled release of canola genetically modified for herbicide tolerance
Monsanto Australia Limited Agricultural Limited and controlled 21 November 2018 Current
Limited and controlled release of canola genetically modified for altered oil content and herbicide tolerance
Nuseed Pty Ltd Agricultural Limited and controlled 6 September 2018 Current
Limited and controlled release of bread wheat and durum wheat genetically modified for enhanced rust disease resistance
CSIRO Agricultural Limited and controlled 11 July 2018 Current
A genetically modified respiratory syncytial virus (RSV) vaccine for use in clinical trials
Novotech (Australia) Pty Ltd Medical Limited and controlled 16 July 2018 Current
Limited and controlled release of perennial ryegrass genetically modified for fructan biosynthesis
Department of Economic Development, Jobs, Transport and Resources Agricultural Limited and controlled 6 March 2018 Surrendered
Limited and controlled release of genetically modified insect-specific viruses as vaccines against Kunjin virus infection in farmed crocodiles
The University of Queensland Medical Limited and controlled 9 May 2018 Current
Commercial release of safflower genetically modified for high oleic acid composition
Go Resources Pty Ltd Agricultural Commercial 27 June 2018 Current
Commercial release of cotton genetically modified for insect resistance (COT102)
Syngenta Australia Pty Ltd Agricultural Commercial 14 February 2018 Current
Limited and controlled release of buffalo grass genetically modified for herbicide tolerance and dwarf phenotype
Royal Melbourne Institute of Technology University Agricultural Limited and controlled 11 April 2018 Current
Commercial release of canola genetically modified for omega-3 oil content (DHA canola)
Nuseed Pty Ltd Agricultural Commercial 13 February 2018 Current
Limited and controlled release of a GM vaccine for chickens, Vaxsafe® ILT
Bioproperties Pty Ltd Agricultural Limited and controlled 1 August 2017 Current
Limited and controlled release of sorghum genetically modified for grain quality traits
University of Queensland Agricultural Limited and controlled 25 July 2017 Current
Limited and controlled release of wheat and barley genetically modified for abiotic stress tolerance and yield improvement
The University of Adelaide Agricultural Limited and controlled 17 July 2017 Surrendered
Limited and controlled release of wheat genetically modified for disease resistance, drought tolerance, altered oil content and altered grain composition
CSIRO Agricultural Limited and controlled 1 May 2017 Current
Limited and controlled release of potato genetically modified for disease resistance
Limited and controlled release of Indian mustard (Juncea canola) genetically modified for altered oil content
Nuseed Pty Ltd Agricultural Limited and controlled 14 February 2017 Current
Commercial supply of Dengvaxia, an attenuated GM dengue vaccine
Sanofi-Aventis Australia Pty Ltd Medical Commercial 27 June 2017 Current
Limited and controlled release of cotton genetically modified for insect resistance and herbicide tolerance
Monsanto Australia Limited Agricultural Limited and controlled 23 January 2017 Current
Limited and controlled release of banana genetically modified for disease resistance
Source – https://www.ogtr.gov.au/what-weve-approved/dealings-involving-intentional-release